Topical compositions and methods of using the same
View Patent ↗The present invention generally relates to topical compositions and methods of using the same. The topical compositions may comprise a hydrophilic composition and a hydrophobic composition in admixture. The hydrophobic composition may include a nitric oxide-releasing compound such as, for example, a diazeniumdiolate functionalized co-condensed silica particle. In some embodiments, the topical composition may be self-emulsifying. Further described herein are kits comprising a hydrophilic composition and a hydrophobic composition.
1. A method of treating skin of a subject, the method comprising:
administering an admixture to the skin of the subject, wherein the admixture is an emulsion and comprises a hydrophobic composition and a hydrophilic composition;
wherein the hydrophilic composition is a hydrogel and comprises a polymer, polyhydric alcohol, and water, wherein water is present in an amount of about 50% to about 99% by weight of the hydrophilic composition; and
wherein the hydrophobic composition comprises a diazeniumdiolate functionalized macromolecule, at least one hydrophobic base, and at least one amphiphilic compound, thereby treating the skin of the subject.
2. The method of claim 1 , further comprising admixing the hydrophobic composition and the hydrophilic composition to form the admixture prior to administering the admixture to the skin of the subject.
3. The method of claim 1 , wherein administering the admixture to the skin of the subject comprises admixing the hydrophobic composition and the hydrophilic composition on the skin of a subject to form the admixture.
4. The method of claim 1 , wherein the polymer is a cellulose or a pharmaceutically acceptable salt thereof, chitosan, an acrylic acid polymer, or any combination thereof.
5. The method of claim 1 , wherein the polyhydric alcohol is present at a concentration from about 5% to about 20% by weight of the hydrophilic composition, and the polymer is present at a concentration from about 0.5% to about 10% by weight of the hydrophilic composition.
6. The method of claim 1 , wherein the admixture is continuous.
7. The method of claim 1 , wherein the admixture has a pH of about 3 to about 9.
8. The method of claim 1 , wherein the diazeniumdiolate functionalized macromolecule comprises a NO-releasing co-condensed silica particle.
9. The method of claim 1 , wherein the hydrophilic composition comprises a buffer.
10. The method of claim 9 , wherein the buffer is a phosphate buffer.
11. The method of claim 9 , wherein the buffer comprises acetic acid and an acetate.
12. The method of claim 1 , wherein the hydrophobic composition further comprises a cosolvent.
13. The method of claim 12 , wherein the hydrophobic composition comprises at least two hydrophobic bases.
14. The method of claim 12 , wherein the cosolvent is a mineral oil.
15. The method of claim 12 , wherein the hydrophobic composition comprises:
the at least one hydrophobic base at a concentration from about 25% to about 98% by weight of the hydrophobic composition;
the at least one amphiphilic compound at a concentration from about 0.5% to about 10% by weight of the hydrophobic composition; and
the cosolvent at a concentration from about 1% to about 20% by weight of the hydrophobic composition; and
wherein the hydrophilic composition comprises:
the polymer at a concentration from about 0.5% to about 10% by weight of the hydrophilic composition; and
the polyhydric alcohol at a concentration from about 5% to about 20% by weight of the hydrophilic composition.
16. The method of claim 1 , wherein the admixture is self-emulsifying.
17. The method of claim 1 , wherein the hydrophilic composition comprises a cellulose or a pharmaceutically acceptable salt thereof.
18. The method of claim 17 , wherein the hydrophilic composition has a pH of about 4 to about 8.
19. The method of claim 1 , wherein the admixture is a continuous emulsion that remains as a single phase for at least 2 days.
20. The method of claim 1 , wherein the ratio of hydrophilic composition to hydrophobic composition is about 1:1, 2:1, or 3:1.
21. The method of claim 1 , wherein the ratio of hydrophilic composition to hydrophobic composition is about 1:1.
22. The method of claim 1 , wherein the diazeniumdiolate functionalized macromolecule is present in the hydrophobic composition at a concentration from about 0.01% to about 30% by weight of the hydrophobic composition.
23. The method of claim 1 , wherein the subject has an inflammatory skin condition or disorder.
24. The method of claim 1 , wherein the subject has a viral, bacterial, or fungal infection.
25. The method of claim 1 , wherein the subject has at least one skin disorder selected from acne, atopic dermatitis, and psoriasis.